Customized autoantibodies (autoAbs) profiling to predict and monitor immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICI)

被引:0
|
作者
Genta, Sofia
Keshavarzi, Sareh
Yee, Noelle
Heirali, Alya
Hansen, Aaron Richard
Siu, Lillian L.
Saibil, Samuel
Stayner, Lee-Anne
Yanekina, Maryia
Sauder, Maxwell
Salawu, Abdulazeez
Spiliopoulou, Pavlina
Vornicova, Olga
Vilbert, Maysa Tamara Silveira
Butler, Marcus O.
Bedard, Philippe L.
Razak, Albiruni Ryan Abdul
Coburn, Bryan
Chruscinski, Andrzej
Spreafico, Anna
机构
[1] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Biostatist, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] Univ Hlth Network, Toronto, ON, Canada
[10] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2528
引用
收藏
页数:1
相关论文
共 50 条
  • [31] In the Clinic Immune-Related Adverse Events of Immune Checkpoint Inhibitors
    Ramos-Casals, Manuel
    Siso-Almirall, Antoni
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (02) : ITC17 - ITC32
  • [32] IMMUNE-RELATED ADVERSE EVENTS (IRAES) MAY INDICATE A FAVORABLE PROGNOSIS IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
    Martini, Dylan
    Evans, Sean
    Goyal, Subir
    Liu, Yuan
    Olsen, T. Anders
    Magod, Benjamin
    Brown, Jacqueline
    Yantorni, Lauren
    Russler, Greta
    Caulfield, Sarah
    Goldman, Jamie
    Nazha, Bassel
    Harris, Wayne
    Master, Viraj
    Kucuk, Omer
    Carthon, Bradley
    Bilen, Mehmet
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A380 - A381
  • [33] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
  • [34] Immune-related adverse events of immune checkpoint inhibitors: a review
    Yin, Qinan
    Wu, Liuyun
    Han, Lizhu
    Zheng, Xingyue
    Tong, Rongsheng
    Li, Lian
    Bai, Lan
    Bian, Yuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Daphne Day
    Aaron R. Hansen
    BioDrugs, 2016, 30 : 571 - 584
  • [36] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Day, Daphne
    Hansen, Aaron R.
    BIODRUGS, 2016, 30 (06) : 571 - 584
  • [37] COST AND HEALTHCARE RESOURCE UTILIZATION (HRU) RESULTING FROM IMMUNE-RELATED ADVERSE EVENTS (IRAES) AMONG PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICIS)
    Zheng, Y.
    Kim, R.
    Yu, T.
    Dreyfus, J.
    Gayle, J. A.
    Wassel, C. L.
    Phatak, H.
    George, S.
    VALUE IN HEALTH, 2019, 22 : S469 - S469
  • [38] Immune checkpoint inhibitors (ICIs) in gastrointestinal (GI) cancer: Immune-related adverse events (IRAEs) and efficacy.
    Das, Satya
    Ciombor, Kristen Keon
    Haraldsdottir, Sigurdis
    Pumpalova, Yoanna S.
    Sahin, Ibrahim Halil
    Shyr, Yu
    Chu, Shih-Kai
    Lin, Emily Pei-Ying
    Hsu, Chih-Yuan
    Goff, Laura Williams
    Cardin, Dana Backlund
    Bilen, Mehmet Asim
    Berlin, Jordan
    Wu, Christina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [40] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS IN SPANISH PATIENTS
    Villalobos, L.
    Giraldo-sifuentes, W. A.
    Moran-alvarez, P.
    Arroyo Palomo, J.
    Briones-figueroa, A.
    Rita, C.
    Morell-hita, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 511 - 511